z-logo
Premium
In vitro approaches to pharmacological screening in the field of atopic dermatitis
Author(s) -
CastexRizzi N.,
Galliano M.F.,
Aries M.F.,
HernandezPigeon H.,
Vaissiere C.,
Delga H.,
Caruana A.,
Carrasco C.,
Lévêque M.,
Duplan H.,
BessouTouya S.
Publication year - 2014
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.13106
Subject(s) - humanities , art , art history , library science , computer science
Summary In vitro models are valuable for evaluating potential active ingredients and other molecules used in medications for atopic dermatitis ( AD ). However, finding appropriate in vitro models can be problematic. Our strategy was to set up different in vitro models that would mimic the pathomechanisms of AD . We describe five such models – the AD keratinocyte model, the AD reconstructed human epidermis model, the adaptive immunity model, the innate immunity model and the pruritus model – which we have used to evaluate a new ingredient for emollients derived from a biological extract. The models chosen provide useful data for the pharmacological characterization of active ingredients in adjunctive treatments for AD .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom